corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 11450

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Ogbogu U.
Canada's approach to conflict- of-interest oversight.
CMAJ 2007 Aug 14; 177:(4):375-6
http://www.cmaj.ca/cgi/content/full/177/4/375-b


Abstract:

In his CMAJ news piece on the proposed US Food and Drug Administration conflict-of-interest rules that would limit the ability of experts with financial interests in the pharmaceutical industry to sit on the agency’s advisory committees, Wayne Kondro highlighted the lack of similar rules in Canada.1 However, recent policy trends indicate that Canada is taking a more restrictive approach by banning experts with nonfinancial conflicts of interest from similar advisory and oversight committees…

Keywords:
Publication Types: Comment Letter MeSH Terms: Advisory Committees* Canada Conflict of Interest* Drug Industry Health Care Sector* Humans United States United States Food and Drug Administration


Notes:

Free full text

Comment on:
CMAJ. 2007 May 22;176(11):1571-2.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.